ARTICLE | Financial News
Cancer play Armo raises $50M series C
February 11, 2016 1:14 AM UTC
Armo BioSciences Inc. (Redwood City, Calif.) raised $50 million in a series C round. Existing investors Kleiner Perkins Caufield & Byers, OrbiMed, DAG Ventures and NanoDimension were joined by new investors HBM Healthcare Investments, GV, Celgene Corp. (NASDAQ:CELG), Industrial Investors Group and funds advised by Clough Capital. ...